19 results · 22ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

NORMED TITANIUM CALCANEUS PLATING WITH LOCKING SCREW SYSTEM

FDA 510(k)
FDA Class 2 ·Orthopedic

MEDI

FDA UDI
MEDI MANUFACTURING, INC.·04047872673167·LEVAMED STABILI-TRI ANK SUP BLU L IV

2040 Ceramic Brackets

FDA UDI
AMERICAN ORTHODONTICS CORPORATION·00190746005848·COSMETIC 20/40 UL LAT 022 T+10 A+8 R=0

Millennium

FDA UDI
Avalign Technologies, Inc.·00190776177782·HEGAR DILATOR

Ophthalmic Knife

FDA UDI
KATENA PRODUCTS, INC.·00841668113332·PHACO KNIFE 3.0MM ANGLED (BX/5)

Specials

FDA UDI
Seaspine Orthopedics Corporation·10889981157326·Cambria Trial without Depth Stop

MODIFIED TO MODULAR FR SEVERE BONE LOSS TRAUMA

FDA 510(k)
FDA Class 2 ·Orthopedic

ACCU-CHEK ACTIVE TEST SYSTEM

FDA 510(k)
FDA Class 2 ·Clinical Chemistry

OT VERIO IQ METER

FDA Adverse Event
Malfunction ·LIFESCAN EUROPE, A DIVISION OF CILAG GMBH INTL·Product code NBW·March 27, 2013

AVAULTA BIOSYNTHETIC SUPPORT SYSTEM - POSTERIOR

FDA Adverse Event
Injury ·SOFRADIM PRODUCTION·Product code FTL·January 26, 2011

COAGUCHEK XS SYSTEM

FDA Adverse Event
Malfunction ·ROCHE DIAGNOSTICS·Product code GJS·March 27, 2008

OT SURESTEP METER

FDA Adverse Event
Injury ·LIFESCAN INC.·Product code NBW·March 31, 2011

OT SURESTEP ENHANCED METER

FDA Adverse Event
Injury ·LIFESCAN INC.·Product code NBW·August 23, 2011

OT SS ENHANCED METER

FDA Adverse Event
Injury ·LIFESCAN INC.·Product code NBW·April 11, 2011

OT SS ENHANCED METER

FDA Adverse Event
Injury ·LIFESCAN INC.·Product code NBW·October 14, 2010

Distal Humeral Plates with Angular Stability with the below descriptions and corresponding article numbers. 1. Cortical Screw, Locking; Article Numbers: 37351-10-N, 37351-12-N, 37351-14-N, 37351-16-N, 37351-18-N, 37351-20-N, 37351-22-N, 37351-24-N, 37351-26-N, 37351-28-N, 37351-30-N, 37351-32-N, 37351-34-N, 37351-36-N, 37351-38-N, 37351-40-N, 37351-42-N, 37351-44-N, 37351-46-N, 37351-48-N, 37351-50-N, 37351-55-N, 37351-60-N, 37351-65-N, 37351-70-N, 37351-75-N, 37351-80-N, 37351-85-N. 2. Humeral Plate, Distal; Article Numbers: 21241-5, 21241-7, 21242-7, 21243-10, 21244-9.

FDA Enforcement
Class II ·Ongoing·I.T.S. GmbH·April 1, 2026

The Propaq LT Series monitors. Model numbers 802LTAN, 802LT0N, and 802LTRN. These devices are indicated for ECG, noninvasive blood pressure (NIBP), respiration and SpO2. The most likely locations for patients to be monitored by these devices are hospital general medical-surgical, telemetry, and intermediate care floors, hospital emergency departments, transport, emergency medical services, and other healthcare applications. intended to be used by clinicians and medically qualified personnel for single or multiparameter vital signs monitoring of ambulatory and nonambulatory patients, including neonate, pediatric and adult patients. These devices are indicated for ECG, noninvasive blood pressure (NIBP), respiration and SpO2. The most likely locations for patients to be monitored by these devices are hospital general medicalsurgical, telemetry, and intermediate care floors, hospital emergency departments, transport, emergency medical services, and other healthcare applications. The monitors can be used as stand-alone devices or as devices networked to an Acuity Central Station through wireless communication over a Welch Allyn FlexNet network.

FDA Enforcement
Class II ·Terminated·Welch Allyn Protocol, Inc·January 15, 2014

Ellipse Implantable Cardioverter Defibrillators (ICDs), Model No. CD1275, CD1311, CD2275, CD2311, CD1411, CD2411 Ellipse ST Implantable Cardioverter Defibrillators (ICDs), Model No. CD1273, CD1309, CD1409, CD2273, CD2309, CD2409.

FDA Enforcement
Class II ·Terminated·St Jude Medical Cardiac Rhythm Management Division·September 10, 2014

CADD-Solis VIP ambulatory Infusion Pumps, Model 2110. Indicated for the following uses: Intra-arterial, subcutaneous, intraperitoneal, in close proximity to nerves, into an intraoperative site, epidural space or subarachnoid space. Therapies that require a continuous rate of infusion, intermittent bolus, and/or with patient-controlled demand doses.

FDA Enforcement
Class I ·Ongoing·Smiths Medical ASD Inc.·August 14, 2024